Bausch Health Companies Inc. (BHC)
NYSE: BHC · Real-Time Price · USD
5.65
-0.30 (-5.04%)
Mar 3, 2026, 10:08 AM EST - Market open
Bausch Health Companies Stock Forecast
Stock Price Forecast
The 3 analysts that cover Bausch Health Companies stock have a consensus rating of "Hold" and an average price target of $8.33, which forecasts a 47.43% increase in the stock price over the next year. The lowest target is $7.00 and the highest is $10.
Price Target: $8.33 (+47.43%)
Analyst Consensus: Hold
Analyst Ratings
The average analyst rating for Bausch Health Companies stock is "Hold". This means that analysts believe this stock is likely to perform similarly to the overall market.
Recommendation Trends
| Rating | Sep '25 | Oct '25 | Nov '25 | Dec '25 | Jan '26 | Feb '26 |
|---|---|---|---|---|---|---|
| Strong Buy | 0 | 0 | 0 | 0 | 0 | 0 |
| Buy | 0 | 0 | 0 | 0 | 0 | 0 |
| Hold | 4 | 4 | 4 | 3 | 4 | 3 |
| Sell | 1 | 1 | 1 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 5 | 5 | 5 | 3 | 4 | 3 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Barclays | Barclays | Hold Maintains $8 → $7 | Hold | Maintains | $8 → $7 | +23.89% | Feb 25, 2026 |
| Truist Securities | Truist Securities | Hold Maintains $7 → $8 | Hold | Maintains | $7 → $8 | +41.59% | Jan 7, 2026 |
| Barclays | Barclays | Hold Initiates $8 | Hold | Initiates | $8 | +41.59% | Dec 9, 2025 |
| RBC Capital | RBC Capital | Hold Maintains $8.5 → $10 | Hold | Maintains | $8.5 → $10 | +76.99% | May 2, 2025 |
| RBC Capital | RBC Capital | Hold Maintains $9 → $8.5 | Hold | Maintains | $9 → $8.5 | +50.44% | Apr 7, 2025 |
Financial Forecast
Revenue This Year
10.70B
from 10.27B
Increased by 4.24%
Revenue Next Year
10.68B
from 10.70B
Decreased by -0.18%
EPS This Year
4.29
from 0.42
Increased by 921.24%
EPS Next Year
3.58
from 4.29
Decreased by -16.54%
Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.
Revenue Forecast
| Revenue | 2026 | 2027 | 2028 | 2029 | 2030 |
|---|---|---|---|---|---|
| High | 11.3B | 11.4B | |||
| Avg | 10.7B | 10.7B | |||
| Low | 10.3B | 10.1B |
Revenue Growth
| Revenue Growth | 2026 | 2027 | 2028 | 2029 | 2030 |
|---|---|---|---|---|---|
| High | 9.9% | 6.4% | |||
| Avg | 4.2% | -0.2% | |||
| Low | 0.0% | -5.8% |
EPS Forecast
| EPS | 2026 | 2027 | 2028 | 2029 | 2030 |
|---|---|---|---|---|---|
| High | 4.89 | 3.94 | |||
| Avg | 4.29 | 3.58 | |||
| Low | 3.64 | 3.27 |
EPS Growth
| EPS Growth | 2026 | 2027 | 2028 | 2029 | 2030 |
|---|---|---|---|---|---|
| High | 1,065.0% | -8.2% | |||
| Avg | 921.2% | -16.5% | |||
| Low | 767.3% | -23.7% |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.